DE69708645T2 - Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression - Google Patents

Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression

Info

Publication number
DE69708645T2
DE69708645T2 DE69708645T DE69708645T DE69708645T2 DE 69708645 T2 DE69708645 T2 DE 69708645T2 DE 69708645 T DE69708645 T DE 69708645T DE 69708645 T DE69708645 T DE 69708645T DE 69708645 T2 DE69708645 T2 DE 69708645T2
Authority
DE
Germany
Prior art keywords
pct
aspirochlorine
derivatives
immune suppression
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69708645T
Other languages
English (en)
Other versions
DE69708645D1 (de
Inventor
Khalid Islam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of DE69708645D1 publication Critical patent/DE69708645D1/de
Application granted granted Critical
Publication of DE69708645T2 publication Critical patent/DE69708645T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69708645T 1996-05-03 1997-04-23 Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression Expired - Lifetime DE69708645T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96106991 1996-05-03
PCT/EP1997/002049 WO1997041862A1 (en) 1996-05-03 1997-04-23 Use of aspirochlorine or derivatives thereof as immunosuppressive agents

Publications (2)

Publication Number Publication Date
DE69708645D1 DE69708645D1 (de) 2002-01-10
DE69708645T2 true DE69708645T2 (de) 2002-08-08

Family

ID=8222742

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69708645T Expired - Lifetime DE69708645T2 (de) 1996-05-03 1997-04-23 Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression

Country Status (13)

Country Link
US (1) US6133254A (de)
EP (1) EP0914129B1 (de)
JP (1) JP4287908B2 (de)
KR (1) KR100439928B1 (de)
AT (1) ATE209493T1 (de)
AU (1) AU705290B2 (de)
CA (1) CA2253635C (de)
DE (1) DE69708645T2 (de)
DK (1) DK0914129T3 (de)
ES (1) ES2163763T3 (de)
IL (1) IL126548A (de)
PT (1) PT914129E (de)
WO (1) WO1997041862A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007287928A (ja) 2006-04-17 2007-11-01 Nec Electronics Corp 半導体集積回路およびその製造方法ならびにマスク

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001086A (en) * 1975-07-18 1977-01-04 Eli Lilly And Company Antibiotic a-30641 and process for production thereof
US3991052A (en) * 1975-07-18 1976-11-09 Eli Lilly And Company Antibiotic A-30641
JP3383718B2 (ja) * 1995-02-15 2003-03-04 ニチモウ株式会社 大豆蛋白を原料とした生成物の製造方法

Also Published As

Publication number Publication date
KR100439928B1 (ko) 2004-12-16
AU2768497A (en) 1997-11-26
JP2000514403A (ja) 2000-10-31
KR20000010724A (ko) 2000-02-25
CA2253635A1 (en) 1997-11-13
ATE209493T1 (de) 2001-12-15
JP4287908B2 (ja) 2009-07-01
IL126548A0 (en) 1999-08-17
DE69708645D1 (de) 2002-01-10
CA2253635C (en) 2006-01-03
US6133254A (en) 2000-10-17
DK0914129T3 (da) 2002-01-28
EP0914129B1 (de) 2001-11-28
WO1997041862A1 (en) 1997-11-13
EP0914129A1 (de) 1999-05-12
IL126548A (en) 2002-02-10
PT914129E (pt) 2002-04-29
AU705290B2 (en) 1999-05-20
ES2163763T3 (es) 2002-02-01

Similar Documents

Publication Publication Date Title
AU2056197A (en) M-amidino phenyl analogs as factor xa inhibitors
AU2534295A (en) Gastrin and cck antagonists
ATE307119T1 (de) Bicyclische protein-farnesyl-transferase inhibitoren
AU1312197A (en) Halogenopyrimidines and their use as pesticides
CY2476B1 (en) Benzonaphthyridines as bronchial therapeutics.
AU2093797A (en) Wood preservative for afterprotection
AU5648496A (en) Pyrazolo-(1,5a)pyrimidines, their preparation and their use
AU5320698A (en) Substituted dihydrobenzofurans as pde inhibitors
DE69713524D1 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative
DE69510545D1 (de) Cck oder gastrin modulierende 5-heterocyclicyl-1,5-benzodiazepine
IT1285777B1 (it) Processo di biotrasformazione di composti colchicinoidi nei corrispondenti 3-glicosilderivati
AP2001002045A0 (en) FKBP inhibitors.
DE69708645D1 (de) Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression
CA2322501A1 (en) Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
SE9700706D0 (sv) Process for the preparation of benzothiazoline compounds
MX9900914A (de)
AU4965593A (en) Ureido-acetamide derivatives, preparation thereof and drugs containing same
PL317538A1 (en) Intermediate compound for obtaining a pharmaceutically active compound
TW349092B (en) Substituted indole derivatives
UY24326A1 (es) Nuevas piperidinas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition